Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial
Clin. Infect. Dis; January 6, 2023
Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
Front Cell Infect Microbiol; January 6, 2023 (eCollection 2022)
Advances in the design of combination therapies for the treatment of tuberculosis
Expert Opin. Drug Discov.; December 28, 2022 (Online ahead of print)
Tuberculosis treatment failure associated with evolution of antibiotic resilience
Science; December 9, 2022
Design principles to assemble drug combinations for effective tuberculosis therapy using interpretable pairwise drug response measurements
Cell Reports Medicine; September 8, 2022
C25-modified rifamycin derivatives with improved activity against Mycobacterium abscessus
PNAS Nexus; September 3, 2022
A genome-wide atlas of antibiotic susceptibility targets and pathways to tolerance
Nat. Commun.; June 7, 2022